Medgate, a self-described "Pioneer in telemedicine with proven expertise and quality services," stands out in the healthcare industry with a substantial track record, having completed over 12 million teleconsultations over more than 20 years. Their model is designed to provide telemedical services to both private and statutory insured self-payers, offering high-quality care via certified, telemedicine-trained physicians.
The company extends its value proposition beyond just traditional consultation through the Medgate app, which grants users 24/7 access to a range of medical services, including prescription issuance, sickness certificates, referrals, and personalized treatment plans. This flexibility and comprehensive approach enhance patient support globally, ensuring care delivery regardless of location.
Despite lacking specific details regarding its founding date or headquarters, Medgate presents an impactful opportunity for investors seeking to enter or expand in the telehealth sector, backed by proven scalability and a strong service ethos.